Cellectis S.A. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K, filed on September 30, 2020, by Cellectis S.A., a foreign private issuer based in Paris, France, announces the scheduling of a Combined Ordinary and Extraordinary General Meeting. The filing serves as a notification to shareholders regarding corporate governance matters rather than a financial performance report.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural notice and does not contain financial statements or key performance indicators.
Material Changes
No material financial changes are reported in this filing. The primary operational change noted is the modification of the shareholder meeting format due to the Covid-19 epidemic. In accordance with French Ordinance No. 2020-321 and Decree No. 2020-925, the meeting will be held "in camera," meaning without the physical presence of shareholders.
Guidance, Outlook, and Management Commentary
The Company will hold its Combined Shareholders' Meeting on November 4, 2020, at 9:30 a.m. Paris time. The agenda includes:
- The appointment of Mr. Jean-Pierre Garnier as a new board member.
- An amendment to the age limit applicable to directors, the chief executive officer, and deputy chief executive officers.
Shareholders cannot physically attend but may be represented and vote under conditions specified in the attached Notice of Combined Shareholders' Meeting (Exhibit 99.1).
Key Facts for Investor Verification
- Meeting Date: November 4, 2020.
- Meeting Format: Virtual/In camera due to pandemic regulations.
- Key Agenda Item: Appointment of Jean-Pierre Garnier to the Board.
- Key Agenda Item: Amendment to director and executive age limits.
- Reference Document: Notice of Combined Shareholders' Meeting (Exhibit 99.1).